Adverum Biotechnologies to Present at the Jefferies Global Healthcare Conference
May 22 2017 - 8:30AM
Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a leading gene therapy
company advancing novel medicines to address unmet needs in serious
rare and ocular diseases, announced today that Amber Salzman,
Ph.D., president and chief executive officer, will present at the
Jefferies Global Healthcare Conference.
|
|
Event: |
Jefferies
Global Healthcare Conference |
|
|
Date: |
June 7,
2017 |
|
|
Time: |
1:30 – 2:00
p.m. ET |
|
|
Location: |
New York,
NY |
|
|
A live and replay video webcast of the presentation will be
available from Adverum’s website at
http://investors.adverum.com.
About Adverum Biotechnologies, Inc.Adverum is a
gene therapy company advancing novel medicines that can offer
life-changing benefits to patients living with serious rare and
ocular diseases. Adverum has a robust pipeline that includes
product candidates designed to treat wet age-related macular
degeneration (wAMD) and rare diseases alpha-1 antitrypsin (A1AT)
deficiency and hereditary angioedema (HAE). Leveraging a
next-generation adeno-associated virus (AAV)-based directed
evolution platform, the Company generates product candidates
designed to provide durable efficacy by inducing sustained
expression of a therapeutic protein. Adverum has collaboration
agreements with Regeneron Pharmaceuticals to research, develop, and
commercialize gene therapy products for ophthalmic diseases and
Editas Medicine to explore the delivery of genome editing medicines
for the treatment of inherited retinal diseases. Adverum’s core
capabilities include clinical development and in-house
manufacturing expertise, specifically in process development and
assay development. For more information please visit
www.adverum.com.
Contacts for Adverum:
Leone Patterson
Chief Financial Officer
Adverum Biotechnologies, Inc.
650-665-7222
lpatterson@adverum.com
Tricia Truehart
Vice President
The Trout Group LLC
646-378-2953
ttruehart@troutgroup.com
Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From Apr 2024 to May 2024
Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From May 2023 to May 2024